New ESG Framework Aims to Transform Pharma Sector's Sustainability Metrics
Key ESG risks highlighted for pharma include climate vulnerabilities, energy consumption, workforce burnout, and data governance gaps—issues laid bare during the pandemic. However, the framework also underscores growth opportunities in digital health, ethical sourcing, green chemistry, and government-backed access programmes like Jan Aushadhi.
Aspire Impact Has Unveiled A Comprehensive ESG Per | 15/07/2025 | By Darshana | 183
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy